Clinical trial
A Multicentre, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech Atrial Flow Regulator in Heart Failure Patients
NCT04405583 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech Atrial Flow Regulator in Heart Failure Patients
- Lead sponsor
- Occlutech International AB
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 28, 2020
- Completion date
- June 30, 2031
- Enrollment
- 150 (estimated)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.